Amlan International Names Dr. Edwin Chow as Technical Service Director to Drive Innovation Across APAC
Rhea-AI Summary
Amlan International (NYSE: ODC) on Dec. 1, 2025 named Edwin Pei Yong Chow, Ph.D., as Technical Service Director, Asia-Pacific (APAC). He will report to Dr. Michael Hua and lead technical service, customer engagement, training, and innovation across APAC.
Dr. Chow has >15 years in animal health, feed additives, and nutrition with prior roles at Berg+Schmidt, Adisseo, and Kemin Industries. He holds a Ph.D. in Chemistry from National University of Singapore and serves as an adjunct assistant professor. The appointment emphasizes Amlan’s focus on mineral-based solutions and regional growth.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, ODC gained 0.86%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Core specialty-chemicals peers such as SCL, ECVT, MATV, KRO, and OEC were all up between 1.35% and 2.94%, while momentum scans only flagged KRO. With the sector flag set to false, the move in ODC appears more company-specific than part of a broad sector rotation.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 10 | Dividend increase | Positive | +3.2% | Board approved a 14% raise in quarterly cash dividend for shareholders. |
| Dec 08 | Earnings release | Neutral | -1.4% | Reported Q1 FY2026 results with softer sales and income versus prior year highs. |
| Dec 03 | Third-party recognition | Positive | -2.3% | Named to Forbes’ 2026 list of America’s Most Successful Small-Cap Companies. |
| Dec 01 | Management appointment | Positive | +0.9% | Appointed Dr. Edwin Chow as Technical Service Director to support APAC growth. |
| Oct 28 | Earnings webcast notice | Neutral | -2.6% | Announced schedule for Q1 2026 earnings discussion and 2025 annual meeting webcast. |
Across five recent events, ODC’s price generally moved in line with news tone, with only one notable divergence on a positive recognition headline.
Over the last few months, Oil-Dri highlighted several shareholder- and reputation-focused milestones. On Dec. 10, 2025, the board approved a 14% dividend increase to $0.205 per common share, following softer but still strong Q1 FY2026 results with $120.5M in net sales and $15.5M in net income reported on Dec. 8. Recognition by Forbes on Dec. 3 underscored long-term performance. The Dec. 1 appointment of Dr. Chow to lead Amlan’s APAC technical efforts fits this trajectory of reinforcing growth and regional strategy.
Market Pulse Summary
This announcement highlighted Oil-Dri’s focus on expanding Amlan’s presence in Asia-Pacific by appointing a seasoned technical leader with more than 15 years of relevant experience. In the weeks around this news, the company paired softer, but historically strong, earnings with a 14% dividend increase and ongoing shareholder returns. Investors may monitor how Dr. Chow’s technical and commercial background translates into Amlan sales trends and broader APAC growth over time.
Key Terms
aquaculture technical
applied materials science technical
AI-generated analysis. Not financial advice.
CHICAGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Amlan International, the animal health business of Oil-Dri Corporation of America (NYSE: ODC), is pleased to announce the appointment of Edwin Pei Yong Chow, Ph.D., as Technical Service Director, Asia-Pacific (APAC). In this role, Dr. Chow will report to Dr. Michael Hua, Regional Director, APAC, and will be responsible for leading Amlan’s technical service tactics across the region, supporting business growth through customer engagement, technical innovation, and training.
With more than 15 years of experience in animal health, feed additives, and nutrition, Dr. Chow brings a wealth of expertise spanning research, product development, technical service, and commercialization. He has held senior scientific and management positions at Berg+Schmidt, Adisseo, and Kemin Industries, where he successfully led regional and global teams focused on developing innovative nutritional and functional solutions for livestock and aquaculture species.
Throughout his career, Dr. Chow has demonstrated a proven ability to translate scientific research into practical applications that deliver measurable performance and profitability for producers. His accomplishments include launching new aquaculture programs across Asia, establishing regional customer testing laboratories, and driving product innovation through collaborative partnerships with universities, government agencies, and industry leaders.
“Dr. Chow brings a unique blend of technical expertise, strategic leadership, and customer-focused insight that will be instrumental in advancing Amlan’s mission to improve animal health and productivity naturally,” said Dr. Michael Hua, Regional Director, APAC. “His deep knowledge of both feed and nutrition positions us to deliver even greater value to our customers across the diverse markets in Asia-Pacific.”
Dr. Chow holds a Ph.D. in Chemistry from the National University of Singapore, where he also serves as an Adjunct Assistant Professor in the Department of Food Science and Technology. His academic and professional achievements are supported by a strong portfolio of published research, patents, and industry contributions that bridgeanimal nutrition, food technology, and applied materials science.
“Joining Amlan is an incredible opportunity to support the future of animal health,” said Dr. Chow. “I am passionate about leveraging science and innovation to deliver mineral-based solutions that not only enhance animal performance but also support the long-term success of animal protein producers. Asia-Pacific is a dynamic region with tremendous potential, and I look forward to building strong partnerships with our distributors and customers that drive growth and create lasting impact.”
Amlan International is the animal health business of Oil-Dri Corporation of America, a leading global manufacturer and marketer of sorbent minerals. Oil-Dri leverages over 80 years of expertise in mineral science to selectively mine and process its unique mineral for consumer and business-to-business markets. Oil-Dri Corporation of America doing business as “Amlan International” is a publicly traded stock on the New York Stock Exchange (NYSE: ODC). Amlan International sells feed additives across the world. Product availability may vary by country; associated claims do not constitute medical claims and may differ based on government requirements. For more information on Amlan International, please visit www.amlan.com.
Contact:
Reagan Culbertson, Vice President of Strategic Marketing, B2B
Reagan.culbertson@amlan.com
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f473b080-667c-4016-ae88-f02be8849617
FAQ
Who is Amlan International appointing as Technical Service Director APAC and when was it announced for ODC?
What responsibilities will Dr. Edwin Chow have at Amlan (NYSE: ODC)?
Who will Dr. Chow report to at Amlan (ODC) and what is the regional focus?
What is Dr. Chow’s background and academic qualification mentioned by Amlan (ODC)?
How does Amlan (NYSE: ODC) say Dr. Chow will impact customers in APAC?
Where can investors find more information about Amlan International and ODC products?
